oxazoles has been researched along with Ventricular Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azam, MA; Bouly, M; Chakraborty, P; Lai, PFH; Massé, S; Nanthakumar, K; Niri, A; Riazi, S; Thollon, C | 1 |
| Asta, J; Azam, MA; Bokhari, MM; Kichigina, G; Labos, C; Lai, PFH; Massé, S; Nanthakumar, K; Porta-Sánchez, A; Si, D; Sun, H; Yang, P; Zamiri, N | 1 |
2 other study(ies) available for oxazoles and Ventricular Fibrillation
| Article | Year |
|---|---|
Effects of azumolene on arrhythmia substrate in a model of recurrent long-duration ventricular fibrillation.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Imidazoles; Oxazoles; Rabbits; Ventricular Fibrillation | 2022 |
Essential role of ryanodine receptor 2 phosphorylation in the effect of azumolene on ventricular arrhythmia vulnerability in a rabbit heart model.
Topics: Animals; Disease Models, Animal; Imidazoles; Isolated Heart Preparation; Male; Oxazoles; Phosphorylation; Rabbits; Ryanodine Receptor Calcium Release Channel; Treatment Outcome; Ventricular Fibrillation | 2018 |